Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
Antipsychotic treatment based on the SNP genotype of DRD2 or ANKK1
Document Type and Number:
Japanese Patent JP6286696
Kind Code:
B2
Abstract:
The present invention relates to the treatment of an individual with an antipsychotic based on individual's genotype at one or more single nucleotide polymorphism (SNP) associated with the dopamine receptor D2 (DRD2) and/or ankyrin repeat and kinase domain containing 1 (ANKK1) genes.

Inventors:
Love dan, christian
Volpi, Simona
Application Number:
JP2016002809A
Publication Date:
March 07, 2018
Filing Date:
January 08, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Vanda Pharmaceuticals, Inc.
International Classes:
C12Q1/68
Domestic Patent References:
JP2008514731A
JP2005512576A
Foreign References:
WO2009036056A1
WO2008144599A1
Other References:
Eur. Neuropsychopharmacol.,2008年12月,Vol.18, No.12,pp.897-907
Mol. Psychiatry,2009年 8月,Vol.14, No.8,pp.804-19
Prog. Neuropsychopharmacol. Biol. Psychiatry,2008年 8月 1日,Vol.32, No.6,pp.1491-5
Am. J. Psychiatry,2001年 5月,Vol.158, No.5,pp.802-4
Pharmacogenetics,2000年 6月,Vol.10, No.4,pp.335-41
Attorney, Agent or Firm:
Ikeda adult
Kazuhiro Yamaguchi
Masakazu Noda
Hiroshi Abe
Sayaka Harada